» Articles » PMID: 33880180

The Global Prevalence of Essential Tremor, with Emphasis on Age and Sex: A Meta-analysis

Overview
Journal J Glob Health
Date 2021 Apr 21
PMID 33880180
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Essential tremor (ET) is one of the most common neurological disorders that impairs quality of life and leads to disability and social handicap. It was estimated that approximate 0.9% of people worldwide were affected by ET. The last decade has seen new investigations on the epidemiology of ET, enabling us to provide an up-to-date estimation of ET prevalence, with emphasis on age and sex.

Methods: We searched PubMed, Medline, Embase and Global Health for studies that reported the prevalence of ET in the general population. Potential sources of heterogeneity were examined by age-adjusted meta-regression. The age- and sex-specific prevalence of ET was constructed with a multilevel mixed-effects meta-regression.

Results: A total of 29 articles were included in our systematic review and meta-analysis. The prevalence of ET increased dramatically with advancing age, where the prevalence estimate in people aged under 20 years was 0.04% (95% confidence interval [CI] = 0.00-0.29) and that in elderly aged 80 years and above was 2.87% (95% CI = 1.07-7.49). ET was consistently more common in males than in females. In 2020, the overall prevalence of ET in the general population was 0.32% (95% CI = 0.12-0.91), and the prevalence was higher in males (0.36%, 95% CI = 0.14-1.03) than in females (0.28%, 95% CI = 0.11-0.79). In 2020, the number of people affected by ET was 24.91million (95% CI = 9.51-70.92), among whom 56% were males.

Conclusions: This study provides an up-to-date estimation of ET prevalence in the general population throughout the whole life span, with emphasis on age and sex. The adoption of an internationally acknowledged diagnostic strategy is prompted in future epidemiological investigations.

Protocol Registration: PROSPERO (CRD42020203979).

Citing Articles

Ultrasound-Guided Botulinum Toxin Infiltrations in Essential Tremor Patients: A 36-week Follow Up.

Salazar G, Caballero I Tremor Other Hyperkinet Mov (N Y). 2025; 15:8.

PMID: 40060174 PMC: 11887461. DOI: 10.5334/tohm.957.


Editorial: Effectiveness of exercise and diet on movement disorders.

Seixas A, Silva C, Bernardo-Filho M, Taiar R, Caputo D Front Aging Neurosci. 2025; 17:1571000.

PMID: 40051466 PMC: 11882572. DOI: 10.3389/fnagi.2025.1571000.


Therapeutic Potential of Agmatine in Essential Tremor Through Regulation of Lingo-1 and Inflammatory Pathways.

Pirmoradi Z, Esmaili Z, Nakhaie M, Kohlmeier K, Shabani M, Razavinasab M Brain Behav. 2025; 15(1):e70241.

PMID: 39779480 PMC: 11710932. DOI: 10.1002/brb3.70241.


Association Between Common Variants in the / Genes and Risk for Essential Tremor.

Agundez J, Macias Y, Alonso-Navarro H, Garcia-Martin E, Alvarez I, Pastor P Int J Mol Sci. 2025; 25(24.

PMID: 39769168 PMC: 11676344. DOI: 10.3390/ijms252413403.


"Quality over quantity:" smaller, targeted lesions optimize quality of life outcomes after MR-guided focused ultrasound thalamotomy for essential tremor.

Buch V, Purger D, Datta A, Wang A, Barbosa D, Chodakiewitz Y Front Neurol. 2024; 15:1450699.

PMID: 39610701 PMC: 11603361. DOI: 10.3389/fneur.2024.1450699.


References
1.
Okubadejo N, Bankole I, Ojo O, Ojini F, Danesi M . Prevalence of essential tremor in urban Lagos, Nigeria: a door-to-door community-based study. BMC Neurol. 2012; 12:110. PMC: 3488469. DOI: 10.1186/1471-2377-12-110. View

2.
Louis E . Essential tremor. Lancet Neurol. 2005; 4(2):100-10. DOI: 10.1016/S1474-4422(05)00991-9. View

3.
Lorenz D, Schwieger D, Moises H, Deuschl G . Quality of life and personality in essential tremor patients. Mov Disord. 2006; 21(8):1114-8. DOI: 10.1002/mds.20884. View

4.
Song P, Liu Y, Yu X, Wu J, Poon A, DeMaio A . Prevalence of epilepsy in China between 1990 and 2015: A systematic review and meta-analysis. J Glob Health. 2018; 7(2):020706. PMC: 5737100. DOI: 10.7189/jogh.07.020706. View

5.
Scharf J, Miller L, Gauvin C, Alabiso J, Mathews C, Ben-Shlomo Y . Population prevalence of Tourette syndrome: a systematic review and meta-analysis. Mov Disord. 2014; 30(2):221-8. DOI: 10.1002/mds.26089. View